Januvia vs. Glipizide
See how Januvia and Glipizide compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Januvia is a once-daily DPP-4 inhibitor, while glipizide is a sulfonylurea taken once, twice, or in an extended-release form once daily.
Glipizide carries a real risk of hypoglycemia and weight gain, while Januvia is weight-neutral and rarely causes low blood sugar on its own.
Glipizide is far less expensive than Januvia, but Januvia has simpler dosing and fewer meal-timing concerns.
Januvia vs. Glipizide Drug Summary
Januvia
Januvia (sitagliptin) is a DPP-4 inhibitor that helps control blood sugar in adults with type 2 diabetes. It's taken as one tablet, once a day, with the dose adjusted for kidney function. Januvia works with the body's own insulin response and is generally weight-neutral.
Glipizide
Glipizide is a sulfonylurea that lowers blood sugar in adults with type 2 diabetes by prompting the pancreas to release more insulin. It's taken as one or two tablets a day, or once daily if using the extended-release form. Glipizide has been used for decades and is widely prescribed.
Januvia vs. Glipizide Side Effects
Januvia
Glipizide
Januvia vs. Glipizide Dosage
Januvia
Glipizide
| STAGE | DOSE | WHEN |
| Starting dose | 100 mg once daily | At the start |
| Maximum dose | 25 mg once daily | If needed |
| Dose changes | 2 increases | As tolerated |
| STAGE | DOSE | WHEN |
| Starting dose | 5 mg once daily | At the start |
| Maximum dose | 5-20 mg once daily | If needed |
| Dose changes | 5 increases | As tolerated |
Januvia
| STAGE | DOSE | WHEN |
| Starting dose | 100 mg once daily | At the start |
| Maximum dose | 25 mg once daily | If needed |
| Dose changes | 2 increases | As tolerated |
Glipizide
| STAGE | DOSE | WHEN |
| Starting dose | 5 mg once daily | At the start |
| Maximum dose | 5-20 mg once daily | If needed |
| Dose changes | 5 increases | As tolerated |
Januvia vs. Glipizide Indications
Januvia
Januvia is FDA-approved as an add-on to diet and exercise for adults with type 2 diabetes. It's often prescribed when metformin alone isn't enough or when a weight-neutral option is preferred. It isn't approved for type 1 diabetes or diabetic ketoacidosis.
Type 2 diabetes blood sugar control
Often added to metformin therapy
Good option for avoiding weight gain
Not approved for type 1 diabetes
Glipizide
Glipizide is FDA-approved as an add-on to diet and exercise for adults with type 2 diabetes. It's often used as an affordable first-line option or added once metformin alone isn't enough. It isn't approved for type 1 diabetes or diabetic ketoacidosis.
Type 2 diabetes blood sugar control
Often used as first-line or add-on therapy
Preferred when low cost is a priority
Not approved for type 1 diabetes
Januvia vs. Glipizide Pros and Cons
Januvia
Januvia offers simple, weight-neutral dosing with a low risk of causing low blood sugar on its own. It costs significantly more than glipizide and carries rare but serious warnings around pancreatitis and joint pain.
Pros
Weight-neutral, unlike sulfonylureas
Low risk of hypoglycemia when used alone
Simple once-daily dosing with no titration
Cons
Roughly $330 to $730 per month without insurance
Rare but serious risk of pancreatitis
Possible severe joint pain with long-term use
Newer drug with less long-term outcome data
Glipizide
Glipizide is inexpensive and has decades of real-world use behind it. It carries a meaningful risk of hypoglycemia and weight gain, and doses need to be timed carefully around meals, especially in older or renally impaired patients.
Pros
Roughly $10 to $35 per month, among the cheapest options
Decades of clinical use and prescribing experience
Available in immediate- and extended-release forms
Cons
Higher risk of hypoglycemia, especially in elderly patients
Can cause weight gain
Requires meal timing to reduce low blood sugar risk
Sulfonylureas linked to possible cardiovascular mortality risk (UGDP study)
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.